Press Releases

Date Title
12/15/17
Summary TogglePulse Biosciences Grants Equity Inducement Awards to New Employees
11/07/17
Summary TogglePulse Biosciences Quarterly Investor Conference Call
11/03/17
Summary TogglePulse Biosciences Announces Transition of Board of Directors, Extends Appreciation to Retiring Members and Welcomes New Board Members
10/24/17
Summary TogglePulse Biosciences to Host Quarterly Investor Conference Call on November 7, 2017
09/25/17
Summary TogglePulse Biosciences Announces $30 Million Private Placement
09/11/17
Summary TogglePulse Biosciences Announces Withdrawal and Planned Resubmission of 510(k) Application for the PulseTxTM System
07/27/17
Summary TogglePulse Biosciences Quarterly Investor and Analyst Conference Call
07/11/17
Summary TogglePulse Biosciences to Host Quarterly Investor Conference Call on July 27, 2017
06/06/17
Summary TogglePulse Biosciences Announces Treatment of First Patient in Study to Evaluate the Safety and Efficacy of Novel Nano-Pulse Stimulation Technology for Seborrheic Keratosis Lesions
05/04/17
Summary TogglePulse Biosciences Quarterly Investor Conference Call
04/17/17
Summary TogglePulse Biosciences to Host Quarterly Investor Conference Call on May 4, 2017
03/14/17
Summary TogglePulse Biosciences Quartery Investor Conference Call
03/14/17
Summary TogglePulse Biosciences Submits 510(k) Application to FDA for PulseTx™ System
03/01/17
Summary TogglePulse Biosciences to Host Investor Conference Call on March 14, 2017
02/10/17
Summary TogglePulse Biosciences Announces Healthcare Executives and Entrepreneurs Robert Duggan and Dr. Maky Zanganeh Have Acquired a Combined Interest of 17.1% of the Company